
The developer of solid-state batteries for electric vehicles reported a notable insider sale, in which the executive completely exited holdings in family trusts.
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

The developer of solid-state batteries for electric vehicles reported a notable insider sale, in which the executive completely exited holdings in family trusts.

Accenture (ACN) stock has gone down for a year while the market has gone up. At around $190, it sits toward the cheap end of its own ten-year history on earnings. The risk sits in what those earnings are made of.

For much of the Iran war, China has helped balance the market by reducing imports of oil. That appears to be changing.

The stock market traded sideways on Friday to wrap the Dow Jones Industrial Average’s worst week since March. The blue-chip index fell 122 points, or 0.2%. The S&P 500 ticked 0.2% higher, while the Nasdaq Composite rose 0.4% and actually finished the week higher.

L3Harris Technologies (NYSE:LHX) is entering its leadership transition with an emphasis on operating execution rather than further portfolio reshaping, according to Chief Financial Officer Ken Sharp. Speaking at a Morgan Stanley aerospace and defense conference, Sharp said new Chief Executive Offic

Data center companies now have an incentive to source their own power.

Cardholders can set spending limits, but just 7% of surveyed fashion shoppers would let AI make purchases without approval.

Visa just posted a fifteenfold jump on a new payment rail while its core business hits records, but the real question is whether stablecoins strengthen its network grip or quietly erode the economics that justify trading near all-time highs.

Key takeawaysNASA awarded Space Exploration Technologies Corp. (NASDAQ:SPCX) three additional astronaut missions worth a combined $946 million.
Healthcare stocks declined late Friday afternoon, with the NYSE Healthcare Index and the State Stree

NetApp (NTAP) has spent years quietly retiring its own stock while the attention went to its flash arrays and AI deals. The stock is not quiet now: it has gained about 92% over the trailing six months and sits roughly 5% below its 52-week high. Fewer shares mean each one carries more of the profit. The question is what that is worth at this price.

Looking back on apparel retailer stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Abercrombie and Fitch (NYSE:ANF) and its peers.

Nscale, a developer of artificial intelligence data centers that counts Nvidia Corp. and Microsoft Corp. among its partners, filed for an initial public offering in New York to tap into AI’s insatiable demand for computing power.

SpaceX's valuation now hovers just below $2 trillion.
Key TakeawaysZscaler’s net new ARR growth (excluding Red Canary) accelerated to 17% year over year in the fiscal fourth quarter, the fastest pace in years, yet FY27 guidance points to that growth cooling back down toward the high teens or lower. Deferred revenue, an independent forward indicator of billings, has decelerated every year since FY22, falling from 62% growth to just 18.

The commerce company has made major inroads into embedded finance, a strategy that could get a boost from partnering with the social media giant's new AI agent.
One of Wendy’s franchisees, operating 314 Wendy’s restaurants across 15 states, or about 5% of Wendy’s U.S. system, filed a voluntary Chapter 11 petition on Thursday.

The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how health insurance providers stocks fared in Q2, starting with CVS Health (NYSE:CVS).

The search giant's in-house AI chip is now a product line. Two companies collect on every system that ships.

Investors have good reason to pay attention to how much money companies distribute back to shareholders.

Warren Buffett has a playbook for moments like this one.
Joby's Historic U.S. Flight Fails to Lift Stock as CEO Sells Shares
Rocket Lab takes a hit as $1.94 billion stock sale fuels dilution worries

DraftKings (DKNG) trades near $22.50, about 14% below the recent high it set on 21st August 2026. Sharp falls in this stock have been worth buying before: the median dip gained 41% over the next twelve months. The same record says the wait was long, and this fall is not the kind it is built on. Consider what those falls paid.

Ethereum ETFs bled hundreds of millions in two days while whale wallets moved in the opposite direction, and the two camps could not have read the same market data more differently.
The real divide may be revenue, not model quality
On is leaning further into its battle with Nike, tapping its former spokesperson.
Can we count your visit with Google Analytics? No ads, no profiles. Details